K2 Advisors Flags Up Fresh Opportunities for Hedge Funds, as Economies Emerge from Coronavirus Carnage (Hedge Week)
Pricing dislocations across a broad range of industries and geographies, coupled with an increasingly fragmented macroeconomic landscape stemming from divergent emergency central bank measures, will throw up a wealth of investment opportunities for macro, equity and credit hedge fund strategies in the second half of 2020, K2 Advisors, the global fund advisory unit of Franklin Templeton, has said. The firm’s third quarter hedge fund strategy outlook pointed to potential economic tailwinds stemming from increased consumer spending post-lockdown, a weakening US dollar, and higher commodity prices.
Founder of a $1.4 Billion Hedge Fund Buys XRP, Hopes to See XRP at All-Time Highs Soon (Herald Sheets)
Former PM at Goldman Sachs, Will Meade, who founded a $1.4 billion hedge fund, has recently made it public that he just bought XRP, which is his first-ever crypto purchase. He shared this new development with his teeming followers on Twitter a couple of hours ago. According to the tweet, Meade has very little knowledge about cryptocurrency, however, he believes that a rise in the leading cryptocurrency, Bitcoin (BTC), is likely to impact XRP as it was in the past.
Thursday 7/9 Insider Buying Report: MLHR, SYNH (Nasdaq.com)
At Miller Herman, a filing with the SEC revealed that on Tuesday, Director Michael A. Volkema purchased 25,000 shares of MLHR, at a cost of $21.44 each, for a total investment of $536,000. Miller Herman is trading up about 1.3% on the day Thursday. Before this latest buy, Volkema made one other purchase in the past year, buying $548,452 shares for a cost of $21.94 each. And at Syneos Health, there was insider buying on Monday, by Director John M. Dineen who bought 8,691 shares for a cost of $59.11 each, for a total investment of $513,725. Syneos Health is trading up about 0.2% on the day Thursday. Bargain hunters can snag SYNH even cheaper than Dineen did, with shares changing hands as low as $55.90 in trading on Thursday — that’s 5.4% below Dineen’s purchase price.
Irhythm Technologies Inc (IRTC) EVP, Sales David A Vort Sold $1.3 million of Shares (Guru Focus)
EVP, Sales of Irhythm Technologies Inc, David A Vort, sold 11,264 shares of IRTC on 07/06/2020 at an average price of $114.34 a share. The total sale was $1.3 million. iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities.
A Director at Science Applications is Exercising Options (Analyst Ratings)
Yesterday it was reported that a Director at Science Applications (SAIC), Robert Bedingfield, exercised options to buy 6,278 SAIC shares at $32.03 a share, for a total transaction value of $201.1K. Following Robert Bedingfield’s last SAIC Buy transaction on September 03, 2015, the stock climbed by 32.9%. Following this transaction Robert Bedingfield’s holding in the company was increased by 31.95% to a total of $1.87 million.
